When a patient is released from the hospital after a heart attack or other major medical event, he or she may be leaving with one or more new medications that potentially conflict(s) with a pre-existing medication regimen. But who is going to flag any potential drug-to-drug interactions, duplicate therapies, gaps in care or other therapy problems? The more patients bounce from doctor to hospital to other sources of care without an advocate monitoring what medications they’re taking (or not taking), the greater the likelihood of costly hospital readmissions or other unfavorable outcomes, including death. How can health plans and PBMs improve the effectiveness of medication reconciliation? What approaches work best? What outcomes have plan sponsors seen with different programs? And how should medication reconciliation be reimbursed? Hear the pros and cons of different strategies from three pharmacy benefit experts with considerable experience observing and addressing medication reconciliation issues.
The On-Demand recording will be available immediately upon purchase* as a link within a PDF file of the accompanying written materials. CDs and printed materials are shipped via USPS.
Three experts in the field — a longtime advocate of medication therapy management programs, and executives from a leading insurer-owned PBM and a health system-owned health plan — discuss the critical components of medication reconciliation and share strategies to address them. You’ll get the answers to these and other thought-provoking questions:
JAN BERGER, M.D., M.J., is chief medical officer at Silverlink Communications. Dr. Berger’s passion is to use communications to engage, educate and empower patients in their health. She is considered a national expert in quality innovation, medication adherence, HEDIS improvement, clinical star measures and consumer health engagement. With more than 25 years of business and clinical expertise, as well as broad international health care experience, Dr. Berger is regarded as one of the top thought leaders in health care. She is the author of more than 100 peer-reviewed journal articles and a frequent speaker on the national stage, and she is often quoted in the national press. As an active participant on numerous national quality and medication safety committees, Dr. Berger has served organizations including the National Committee on Quality Assurance, the National Quality Forum, the American Academy of Pediatrics, the American Medical Association and many others. She is editor in chief of the American Journal of Pharmacy Benefits. Prior to joining Silverlink, Dr. Berger was senior vice president and chief clinical officer of CVS Caremark. She earned her medical degree and a Master’s degree in health law from Loyola University. She holds a Six Sigma Black Belt from the American Society of Quality and a certificate in business from the University of South Florida.
BRIAN SOLOW, M.D., F.A.A.F.P., currently serves as the chief medical officer for OptumRx. In this capacity, his primary responsibilities include leading the Clinical Services team and guiding their tactical and strategic endeavors. During his tenure at OptumRx, Dr. Solow and his team have introduced evidence-based clinical programs, emphasizing balanced consideration for the clinical interests of patients, prescribing health care professionals and clients based on sound, scientific data, including the Medication Therapy Management (MTM) and Disease Therapy Management (DTM) programs. Prior to becoming the chief medical officer, Dr. Solow served as the vice president, senior medical director. He has more than 25 years of experience as a practicing physician and has previously served as a member of national pharmacy and therapeutics committees for leading managed care and pharmacy benefit management organizations. Prior to joining OptumRx, Dr. Solow was an active member of a physician-owned medical group, maintaining a full-time practice while simultaneously engaging in various administrative roles for the group, chairing key committees and serving as a member of the group’s board of directors. He has also lectured extensively on managed care topics such as medication therapy management and quality improvement issues. Dr. Solow earned his medical degree from New York Medical College in Valhalla, N.Y. He completed his family practice residency at the University of California, Los Angeles/Northridge Hospital Medical Center and maintains board certification in his specialty. Dr. Solow holds active appointments at the University of Southern California School of Pharmacy and the University of California, San Francisco School of Pharmacy, in conjunction with the OptumRx pharmacy resident program.
DEAN T. PARRY, R.Ph., is director of Pharmacy Clinical Programs at Geisinger Health Plan. Mr. Parry graduated from Philadelphia College of Pharmacy and Science in 1981 with a B.S. in Pharmacy. After graduation he worked as a pharmacist at Geisinger Medical Center. In January 1985, he accepted a position as Chief Pharmacist at Macha Mission Hospital in Choma, Zambia, Africa. Mr. Parry was deeply involved in the leadership of the Churches Medical Association of Zambia and also in the area of research related to the treatment of malaria, on which he has co-authored several research articles. On his return to the United States in 1995, he again accepted a position at Geisinger Medical Center and has been actively involved in various areas including health care redesign projects in the late 1990s and the development of various pharmaceutical care programs for the organization. In his current position, Mr. Parry is responsible for ambulatory and acute care clinical pharmacy programs throughout the health system. He also works closely with health system leadership in the development of processes and guidelines for appropriate utilization of medications.
Moderator: BJ Taylor, associate editor of AIS's Health Plan Week
Pharmacy, clinical services and medical directors; strategic planners; product development, contracting and marketing executives; and financial and operations executives at
CDs (and accompanying written materials) are shipped via UPS. Please give us your street address when you order (UPS does not deliver to PO boxes). You should receive your order within two weeks.* Shipping and handling cost is $12.
The On-Demand Recording will be delivered as a link within a PDF file of the accompanying written materials. Shipping will NOT be charged for this item.
Rush Orders: Please call us at 800-521-4323 to place a rush order.* We will overnight your order for an additional charge of $30, or you can give us your FedEx or UPS account number and we will charge the shipping to your account. Rush orders placed after 3:00pm EST will not be shipped out until the next business day.
*On-Demand recordings will be available within a week of the conference and CDs will be available within two weeks.
Listeners will also receive practical written information to supplement information covered by the Webinar speakers. A copyright release in the Printed Materials will permit you to make photocopies for each person listening to the Webinar and/or the On-Demand Recording.
Listen at your convenience to recent webinars with On-Demand or CD options!
Renew your subscriptions to AIS newsletters and looseleaf publications at the Renewal Center